Clinical Trial Services
End-to-end operational support from feasibility and site identification through study start-up, monitoring, and coordination.
- Trial feasibility
- Site identification
- Study start-up
- Clinical operations
Calebyte BioSolutions
The Contract Research Organization of CaleByte Health & Innovations
CRO overview
Calebyte BioSolutions is the Contract Research Organization (CRO) arm of CaleByte Health & Innovations. We help pharmaceutical, biotechnology, academic, and public health sponsors plan and run high-quality clinical research in African populations, starting in Ethiopia.
African populations remain under-represented in the clinical research that shapes global medicine. We work to change that responsibly by pairing international standards with local regulatory knowledge, site partnerships, and data operations designed for the settings where studies take place.
Who we serve
Expanding development programs to include diverse African populations.
Seeking practical, well-governed pathways to run studies in new regions.
Running investigator-initiated and collaborative research programs.
Generating evidence for programs, interventions, and health policy.
CRO services
End-to-end operational support from feasibility and site identification through study start-up, monitoring, and coordination.
Regulatory strategy, submissions, and ethics committee coordination that keep your study compliant and participants protected.
Prepare research sites with the infrastructure, people, workflows, and quality systems needed to run studies to international standards.
Clinical data management, quality control, biostatistics, and analytics that turn study data into reliable evidence.
Safety reporting, adverse event documentation, and pharmacovigilance processes that protect participants and meet reporting obligations.
Digital workflows, data infrastructure, interoperability, and responsible AI that modernize how clinical research is run.
Study lifecycle
Why Calebyte BioSolutions
Study plans shaped by local health systems, languages, and infrastructure from day one.
Grounded in FDA, EFDA, WHO, and ICH Good Clinical Practice expectations.
Participant protection, informed consent, and community engagement built into every study.
Data management, biostatistics, and technology designed for quality and traceability.
Share your protocol stage, therapeutic area, and timelines. We will help you understand feasibility and next steps.